Trials / Completed
CompletedNCT00310700
Kinetics of B Cell Response in Infants Menjugate Vaccination
A Phase IV, Single Centre, Open-label Study to Investigate the Kinetics of the B Cell Response to the First and the Third Immunization With Chiron Meningococcal C Conjugate Vaccine Administered to Healthy Infants at 2, 3 and 4 Months of Age
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (planned)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 8 Weeks – 11 Weeks
- Healthy volunteers
- Accepted
Summary
Kinetics of B cell response in infants Menjugate vaccination
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Meningococcal C conjugate vaccine |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2005-11-01
- Completion
- 2005-11-01
- First posted
- 2006-04-04
- Last updated
- 2014-09-19
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00310700. Inclusion in this directory is not an endorsement.